Glomerulonephritis is a renal disorder characterized by damage to the glomeruli, the kidneys' filtering units. Per GARD (NIH), the condition may be acute or chronic, focal or diffuse, and can progress to renal failure. Established causes include autoimmune disorders, infections, diabetes, and malignancies. Prevalence and onset data are not documented in this packet.

Specific phenotypic features for the broad diagnostic grouping are not enumerated in this packet. The condition encompasses 20 documented subtypes including acute poststreptococcal glomerulonephritis, IgA glomerulonephritis, membranous glomerulonephritis, lupus nephritis, rapidly progressive glomerulonephritis, and granulomatosis with polyangiitis, each associated with distinct clinical presentations.

Glomerulonephritis arises from autoimmune disorders, infections, diabetes, and malignancies, per the packet definition. Genetic associations are not catalogued in this packet, consistent with the predominantly acquired nature of the condition.

Diagnostic criteria, biomarkers, and screening protocols for the broad glomerulonephritis category are not catalogued in this packet. Clinical characterization varies substantially across subtypes.

No FDA-approved treatments are documented in this packet for glomerulonephritis as a broad diagnostic category. Individual subtypes may carry separate regulatory designations.

Natural history data are not populated in this packet. The packet definition notes the condition may progress to renal failure, representing one documented disease course outcome.

ClinicalTrials.gov lists 42 active trials. Registered studies include a Phase 2 trial of daratumumab for proliferative glomerulonephritis with monoclonal immune deposits (NCT05654506, Mayo Clinic), a Phase 3 study of iptacopan in C3G or IC-MPGN (NCT03955445, Novartis), and a Phase 3 open-label extension of zigakibart in IgA nephropathy (NCT06858319, Novartis). The research landscape includes 209 classified publications, with reviews and meta-analyses as the dominant publication type.